
Clinical Research Management Briefing – February 26, 2018
Top Stories
A history of unethical biomedical treatment in African-American communities could make recruiting patients difficult for researchers.
STAT, February 21
Trump Pushing Ahead on Koch-Backed Experimental Drugs 'Right to Try' Agenda
Bypassing the Food and Drug Administration's clinical-trial process is raising safety and ethical concerns among patient-advocacy organizations.
CNBC, February 21
Huron Spotlight
Emory University Goes Live on Huron IACUC 8.1
In just five months, Emory University deployed Huron IACUC to streamline operations and better manage its protocols.
Huron
Financial and Operations
Distributed Ledgers Can Streamline Clinical Trials
New technology has the potential to streamline healthcare processes – bringing new drugs to the market faster and at a lower price.
Nasdaq, February 15
Technology
Sensors and Wearables Transform Clinical Trials but Challenges Remain, Experts Say
Inconsistencies in the way devices measure, report and collect data make selecting the right device even more important.
CenterWatch, February 19
Pharma/Bio-Tech
What Pharma Companies Need to Know about FDA's New Draft IVD Guidance
With the increased use of in vitro diagnostics (IVDs), pharmaceutical and biotech companies need to develop guidelines for risk evaluation and consideration.
Applied Clinical Trials, February 12
Contact UsSubscribe to Huron Insights
Sign Up Today!Clinical Research Management Briefing – February 26, 2018
-
Rick Rohrbach
Managing Director
Industry:
Higher Education | Healthcare | Technology Media and Telecommunications | Life Sciences | Retail
-
Leah Guidry
Managing Director
Industry:
Higher Education | Healthcare | Life Sciences